Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Coeptis Therapeutics Holdings (COEPW) Operating Expenses (2021 - 2025)

Coeptis Therapeutics Holdings has reported Operating Expenses over the past 5 years, most recently at $2.8 million for Q4 2025.

  • Quarterly results put Operating Expenses at $2.8 million for Q4 2025, up 29.74% from a year ago — trailing twelve months through Dec 2025 was $14.2 million (up 41.49% YoY), and the annual figure for FY2025 was $14.2 million, up 41.49%.
  • Operating Expenses for Q4 2025 was $2.8 million at Coeptis Therapeutics Holdings, up from $2.7 million in the prior quarter.
  • Over the last five years, Operating Expenses for COEPW hit a ceiling of $15.7 million in Q1 2022 and a floor of $100017.0 in Q3 2021.
  • Median Operating Expenses over the past 5 years was $3.2 million (2022), compared with a mean of $4.7 million.
  • Peak annual rise in Operating Expenses hit 11004.82% in 2022, while the deepest fall reached 77.82% in 2022.
  • Coeptis Therapeutics Holdings' Operating Expenses stood at $13.7 million in 2021, then plummeted by 77.82% to $3.0 million in 2022, then rose by 10.6% to $3.4 million in 2023, then tumbled by 35.76% to $2.2 million in 2024, then rose by 29.74% to $2.8 million in 2025.
  • The last three reported values for Operating Expenses were $2.8 million (Q4 2025), $2.7 million (Q3 2025), and $4.7 million (Q2 2025) per Business Quant data.